DNA ‘Reverse’ Vaccine Reduces Levels of Immune Cells Believed Responsible for Type 1 Diabetes

On November 3, 2013, in Articles, Clinical Trials, News, by RCTherapy

June 26, 2013 – Read Full Article on Science Daily A clinical trial of a vaccine, led by Stanford University School of Medicine researchers and designed to combat type-1 diabetes, has delivered initially promising results, suggesting that it may selectively counter the errant immune response that causes the disease. Several important findings of the multicenter, […]

Dr. Huerta on the Arizona Midday Show

On September 13, 2013, in Articles, News, by RCTherapy

Researchers Target HER1 Receptor for Peptide Cancer Vaccine

On August 1, 2013, in Articles, by RCTherapy

Researchers Target HER1 Receptor for Peptide Cancer Vaccine, Therapeutic Agents Small proteins called peptides that consist of 10 to 50 amino acids are being studied as cancer vaccines and as possibly safer, more effective and less costly alternatives to the monoclonal-antibody-based drugs and small-molecule inhibitors now used to treat many malignancies. Researchers at The Ohio […]

Alzheimer’s Movie Sponsor

On June 24, 2013, in Articles, News, by RCTherapy

RCT Sponsors Alzheimer’s movie, It Snows All The Time, based on a true story. Read More at www.itsnowsallthetime.com RCT Founders Hans and Jonas with Leading Actor Brett Cullen.  

Alternative Treatments for Diabetes

On March 21, 2013, in Articles, Clinical Trials, News, by RCTherapy

Original Article Source Never need insulin injections again! A peptide synthesized by Israeli researchers provides a radically improved weapon against Type 1 diabetes, stopping it at its source. Israeli drug maker Teva Pharmaceutical Industries and Clal Biotechnology Industries (CBI) have more than $40 million riding on an Israeli-innovated treatment for Type 1 diabetes now in […]

Experimental Therapy Crosses Blood-brain Barrier to Treat Neurological Disease

On February 17, 2013, in Articles, Clinical Trials, by RCTherapy

February 4, 2013 in Medical research Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice. Posted online in PNAS Early Edition on Feb. 4, the study was led by scientists at Cincinnati Children’s Hospital Medical […]

Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis

On February 17, 2013, in Articles, Clinical Trials, by RCTherapy

Read Full Report   Abstract Osteoarthritis (OA) affects over 40 million people annually. We evaluated interleukin-1 receptor antagonist (IL-1ra) gene transfer in an equine model based on IL-1ra protein therapy which inhibits inflammation through blocking IL-1. Using the self-complementary adeno-associated virus (scAAV)IL-1ra equine gene as a starting construct, we optimized the transgene cassette by analyzing […]

Senator, Mayor & Other Officials Visit the New RCT Clinic

On February 2, 2013, in Articles, News, by RCTherapy

Regenerative Cellular Therapy thanks all its supporters in the medical and governing arenas. We encourage others to come visit our newly completed clinic and see our results firsthand. Below is a new photo in front of our new RCT Clinic during our recent visit from Senator Claudia Pavlovich Arellano in Rocky Point. Accompanying us was […]

The Promise Of Peptides And Proteins

On December 17, 2012, in Articles, by RCTherapy

By Gary Hu American Peptide Company With the strong growth in biologics, large molecules, and bio-pharmaceutical therapeutics in recent years, the pharmaceutical and biotech industries are increasingly turning toward peptides and proteins in the search for drug discovery targets. While both proteins and peptides possess numerous properties that offer significant therapeutic potential, there are fundamental […]

Experimental Peptides Prevent Diabetes & Halt Its Progression

On December 17, 2012, in Articles, Clinical Trials, by RCTherapy

News: Just released by the University of South Carolina. By LESLIE H. LANG UNC-CH School of Medicine CHAPEL HILL — Injections of protein fragments prevented the development of type-I diabetes in a strain of mice prone to the disease, according to scientists at the University of North Carolina at Chapel Hill. The peptide injections also […]

Multiple Myeloma Treatment

On February 8, 2012, in Articles, Clinical Trials, by RCTherapy

Apigenin inhibits proliferation and induces apoptosis through targeting the trinity of CK2, Cdc37 and Hsp90. 2011 BioMed Research – Abstract – Background: Multiple myeloma (MM) is a B-cell malignancy that is largely incurable and is characterized by the accumulation of malignant plasma cells in the bone marrow. Apigenin, a common flavonoid, has been reported to […]

Clinical Analysis of the Fibroblast Growth Factor

On December 28, 2011, in Articles, Clinical Trials, by RCTherapy

NEUROTROPHIC FACTORS: Published:  Monday, October 24th, 2011 Download the complete Report Here. In this publication we will give you a general overview of Neurotrophic Factors and the Neurophysiological Evaluation we applied. Studies are being made for consistency and power analysis relating to events, this is a test that evaluates the answers or voltages generated by […]

© 2013 Regenerative Cellular Therapy
Terms and Conditions     |     Privacy Policy     |     Sitemap